ArticleBMC microbiology2026
Rare-codon-tuned fluorescent biosensor for high-throughput selection of Escherichia coli strain capable of L-arginine overproduction.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRapid advancements in complex engineered metabolic system design have not been matched by corresponding screening and identification capabilities for high-performing microbial variants, creating considerable pacing constraints in strain development. Therefore, advancing high-throughput phenotyping methods is essential for propelling synthetic biology and metabolic engineering towards scalable biomanufacturing.
resultsAccordingly, we developed a rare codon-dependent fluorescent biosensor that enables real-time, high-content monitoring of intracellular L-arginine accumulation. This system employed L-arginine-rich peptide modules that are engineered with AGG rare codons fused to the StayGold fluorescent protein, developing a stringent link between fluorescence intensity and cytoplasmic L-arginine levels. By integrating ultraviolet mutagenesis with fluorescence-activated cell sorting, we efficiently isolated superior producers from an engineered Escherichia coli ARG library, achieving a screening efficiency of 55.12%. The top-performing isolate, E. coli ARG-B10, exhibited a 94.8% enhancement in L-arginine production. Its plasmid-cured derivative, E. coli B10, was used for scale-up fermentation, attaining a 120.5 g/L titer and 0.45 g/g glucose yield under industrially relevant conditions. Genomic analysis revealed missense mutations in key metabolic genes (coaBC, gst, yihU, and fruB), indicating improvements in the precursor supply and redox management.
conclusionThis biosensor platform operates independently of orthogonal translation systems and is readily applicable to wild-type strains, offering a powerful and generalizable tool for accelerating microbial strain optimization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.